SCHOTT Pharma AG & Co. KGaA, located in Germany, operates in the Healthcare industry and holds a medium ESG risk rating score of 22.0. The company specializes in providing containment solutions and delivery systems for injectable drugs to the pharma, biotech, and life science sectors. Its key segments are Drug Containment Solutions (DCS) and Drug Delivery Systems (DDS), with a focus on products such as vials, cartridges, and ampoules. SCHOTT Pharma AG & Co. KGaA generates revenue from regions including Europe, Middle East, Africa, Asia, South Pacific, North America, and South America.